Outpatient drug safety: new steps in an old direction. Pharmacoepidemiol Drug Saf 2007 Feb;16(2):160-5
Date
04/25/2006Pubmed ID
16634121DOI
10.1002/pds.1242Scopus ID
2-s2.0-33847192874 (requires institutional sign-in at Scopus site) 36 CitationsAbstract
Iatrogenic injury from adverse drug events (ADEs) is a common and often preventable problem in modern medical practice. Attention to this problem has focused on the inpatient hospital setting and healthcare professionals. However, most medication is prescribed and used outside of hospitals and is managed by patients or lay caregivers in homes or workplaces. To address the public health problem of outpatient drug safety, interventions to prevent adverse events must recognize the central role of the patient in medication management and environmental factors specific to the outpatient setting. Lessons and techniques from the field of injury prevention should guide the development and implementation of safety interventions. First, Haddon's phase-factor matrix can be used to help conceptualize outpatient drug safety interventions. Second, interventions to improve outpatient drug safety should be patient-centered and extend beyond patient education to include engineering innovations and enforcement strategies. Third, the sustainability of active versus passive interventions should be considered when choosing safety interventions.
Author List
Budnitz DS, Layde PMAuthor
Peter M. Layde MS, MD Emeritus Professor in the Emergency Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Ambulatory CareDrug-Related Side Effects and Adverse Reactions
Health Knowledge, Attitudes, Practice
Humans
Medication Errors
Models, Theoretical
Patient Education as Topic
Patient Participation
Quality of Health Care
Risk Management
Safety Management
Socioeconomic Factors
United States
